About Atlanta Pharmaceuticals Private Limited
Data last updated:
Atlanta Pharmaceuticals Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 December 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U52311UP2000PTC025804.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rahul Jain and Archana Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 202 Iind Floor Plot No. 596 W Block Juhi Saket Nagar, Kanpur, Uttar Pradesh, India – 208014.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website atlantabiotec.com.
Company details
Contact details
Atlanta Pharmaceuticals Private Limited's registered office is in Kanpur, Uttar Pradesh. Its website is atlantabiotec.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No. 202 Iind Floor Plot No. 596 W Block Juhi Saket Nagar, Kanpur, Uttar Pradesh, India – 208014
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Atlanta Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Atlanta Pharmaceuticals Private Limited
FY 2025 filings availableAtlanta Pharmaceuticals Private Limited reported revenue of ₹5,500 (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 10% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 9%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Atlanta Pharmaceuticals Private Limited, buy the company report.
Board of directors of Atlanta Pharmaceuticals Private Limited
Atlanta Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Jain Also directs: Udaytrishi LLP, Saharsh Commerce LLP | Director | 27 Dec 2000 | 25 Years 10 Months | Current |
| Archana Jain | Director | 27 Dec 2000 | 25 Years 10 Months | Current |
Peer comparison
Atlanta Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neuvocare Pharmaceuticals Private Limited | ₹5,901 (FY 2024) | Nashik, Maharashtra, India | ||||
| Tammermeds Pharmaceuticals Private Limited | ₹5,860 (FY 2025) | Baddi, Himachal Pradesh, India | ||||
| Medheart Pharmaceuticals Private Limited | ₹5,727 (FY 2025) | -95.0% | Noida, Uttar Pradesh, India | |||
| Philanthropy Pharmaceuticals Private Limited | ₹5,652 (FY 2024) | -83.0% | Nawabganj, Uttar Pradesh, India | |||
| Sanyasi Pharmaceuticals Private Limited | ₹5,589 (FY 2025) | 6.0% | New Delhi, Delhi, India | |||
| Atlanta Pharmaceuticals Private Limitedthis company | ₹5,500 (FY 2025) | 10.0% | Kanpur, Uttar Pradesh, India | |||
| Atlantic World Private Limited | ₹5,400 (FY 2025) | 74.0% | Delhi, India | |||
| Allensia Pharmaceuticals Private Limited | ₹5,292 (FY 2025) | -62.0% | Surat, Gujarat, India | |||
| Proyurveda Lifescience Private Limited | ₹5,280 (FY 2022) | -92.0% | Valsad, Gujarat, India | |||
| Vitarag Pharmaceuticals Private Limited | ₹5,066 (FY 2025) | Rajkot, Gujarat, India | ||||
| Zayden Pharmaceuticals Private Limited | ₹5,040 (FY 2023) | -89.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Atlanta Pharmaceuticals Private Limited, buy the company report.
Auditor
Atlanta Pharmaceuticals Private Limited is audited by RAJANI MUKESH & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJANI MUKESH & ASSOCIATES | FY 2020 | 004072C |
Shareholding
The shareholding of Atlanta Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Atlanta Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Atlanta Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Atlanta Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Atlanta Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Atlanta Pharmaceuticals Private Limited has 3 board changes on record since 2000: 2 appointments and 1 cessation. The latest: Ashesh Agarwal ceased to be Director on 29 Jan 2022.
Frequently asked questions
Atlanta Pharmaceuticals is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 December 2000 (26+ years old) and is registered under CIN U52311UP2000PTC025804.
Atlanta Pharmaceuticals has 2 current directors:
- Rahul Jain - Director
- Archana Jain - Director
The latest financial statements of Atlanta Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Atlanta Pharmaceuticals is U52311UP2000PTC025804. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Atlanta Pharmaceuticals was incorporated on 27 December 2000, making it 26+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Atlanta Pharmaceuticals by revenue are Neuvocare Pharmaceuticals Private Limited, Tammermeds Pharmaceuticals Private Limited, Medheart Pharmaceuticals Private Limited, Philanthropy Pharmaceuticals Private Limited, Sanyasi Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Ashesh Agarwal ceased to be Director on 29 Jan 2022. Archana Jain was appointed as Director on 27 Dec 2000. Rahul Jain was appointed as Director on 27 Dec 2000.
Atlanta Pharmaceuticals can be reached through the website atlantabiotec.com. Its registered office is in Kanpur, Uttar Pradesh, India.
The registered office of Atlanta Pharmaceuticals is at Flat No. 202 Iind Floor Plot No. 596 W Block Juhi Saket Nagar, Kanpur, Uttar Pradesh, India – 208014.
Atlanta Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Atlanta Pharmaceuticals is compliant as of 29 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
